High tumoral LOX‐1 expression (tumoral LOX‐1‐H group) was identified in 39.1% (50/128) of the CRC specimens, while low tumoral LOX‐1 expression (tumoral LOX‐1‐L group) was identified in 60.9% (78/128) of the specimens. This evidence concerns the gene OLR1 and colorectal carcinoma.